Why the study?
Does meloxicam 7.5 mg once daily improve gastrointestinal tolerability compared to piroxicam 20 mg once daily in patients with exacerbation of osteoarthritis?
Does meloxicam 7.5 mg once daily improve gastrointestinal tolerability compared to piroxicam 20 mg once daily in patients with exacerbation of osteoarthritis?
Meloxicam 7.5 mg once daily demonstrates improved gastrointestinal tolerability compared to piroxicam 20 mg once daily in patients with osteoarthritis exacerbation.
No takes yet. Share an insight, caveat, or question.
Meloxicam improves GI tolerability versus piroxicam in osteoarthritis exacerbation; supports preferential NSAID selection in patients with GI risk.
Dequeker et al. (1998) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: